Stay updated on Seagen Press Releases
Sign up to get notified when there's something new on the Seagen Press Releases page.

Latest updates to the Seagen Press Releases page
- Check6 days agoChange DetectedAdded Medicines and Research and Pipeline categories and published the 02.17.2026 press release Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer. Removed the Research and Corporate categories and deleted the 12.09.2025 press release Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma.SummaryDifference2%

- Check13 days agoChange DetectedAdded two new press releases: Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans (Corporate, 02.05.2026) and FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need (02.06.2026). Removed two December 2025 press releases: Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance (12.01.2025) and HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors (12.06.2025).SummaryDifference3%

- Check20 days agoChange DetectedAdded new press releases dated December 2025 to February 2026, including 'Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance' and 'Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss...'. Removed older items and the 'Prescription Medicines' category, reducing earlier posts such as the 11.21.2025 PADCEV+Keytruda and 11.13.2025 Metsera announcements.SummaryDifference8%

- Check35 days agoChange DetectedA United States regional filter option was added to the press releases page filters. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check42 days agoChange DetectedAdded a new press release entry for Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer (01.10.2026) and introduced navigation items 'Medicines' and 'Research and Pipeline'. Removed the older press release 'Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference' (11.12.2025).SummaryDifference2%

- Check49 days agoChange DetectedAdded a January 5, 2026 press release titled 'Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference' and introduced Finance and Financial as page categories/filters. Removed the older press release 'Pfizer Responds to Delaware Chancery Court Ruling' (11.05.2025).SummaryDifference2%

Stay in the know with updates to Seagen Press Releases
Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.